Although these six ceramide synthases have a common role in altering ceramide metabolism, the other five ceramide synthetases do not share the role of LASS2 in cancers, suggesting that other underlying mechanisms in addition to ceramide metabolism, should be considered. This evidence concerns the gene CERS2 and cancer.